These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13663018)

  • 1. Hormonal therapy of metastatic female breast carcinoma. I. 9 alpha-Bromo-11-ketoprogesterone.
    GOLDENBERG IS; HAYES MA
    Cancer; 1959; 12(4):738-40. PubMed ID: 13663018
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and pharmacological observations of the effects of 9-alpha-bromo-11-beta-ketoprogesterone in patients with carcinoma of the breast.
    JONSSON U; COLSKY J; LESSNER HE; ROATH OS; ALPER RG; JONES R
    Cancer; 1959; 12(3):509-20. PubMed ID: 13652098
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of pituitary gonadotropins by 17-ethynyl-19-nortestosterone in patients with metastatic carcinoma of the breast.
    MARTIN L; CUNINGHAM K
    J Clin Endocrinol Metab; 1960 Apr; 20():529-33. PubMed ID: 14421705
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal therapy in cancer of the breast 16. The effect of Delta 1-testololactone on clinical course and hormonal excretion.
    SEGALOFF A; WEETH JB; RONGONE EL; MURISON PJ; BOWERS CY
    Cancer; 1960; 13():1017-20. PubMed ID: 13749676
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies with 19-norethisterone oenanthate in mammary carcinoma.
    DOUGLAS M; LORAINE JA; STRONG JA
    Proc R Soc Med; 1960 Jun; 53(6):427-31. PubMed ID: 13817831
    [No Abstract]   [Full Text] [Related]  

  • 6. Objective remission of metastatic breast carcinoma in a male who recieved 17-alpha hydroxy progesterone caproate (delalutin).
    GELLER J; VOLK H; LEWIN M
    Cancer Chemother Rep; 1961 Oct; 14():77-81. PubMed ID: 13897631
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal therapy of metastatic female breast carcinoma. II. 2alpha-Methyl dihydrotestosterone propionate.
    GOLDENBERG IS; HAYES MA
    Cancer; 1961; 14():705-6. PubMed ID: 13706491
    [No Abstract]   [Full Text] [Related]  

  • 8. 9 alpha-Bromo-11-ketoprogesterone; another new orally effective substance with progestational activity.
    WIED GL; DAVIS ME
    Obstet Gynecol; 1957 Oct; 10(4):411-7. PubMed ID: 13477602
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormonal treatment of metastatic carcinoma of the breast.
    BAKER WH; KELLEY RM; SOHIER WD
    Am J Surg; 1960 Apr; 99():538-43. PubMed ID: 13796040
    [No Abstract]   [Full Text] [Related]  

  • 10. Does hormonal therapy have a therapeutic role in metastatic primary small cell neuroendocrine breast carcinoma? Case report and literature review.
    Alkaied H; Harris K; Brenner A; Awasum M; Varma S
    Clin Breast Cancer; 2012 Jun; 12(3):226-30. PubMed ID: 22424945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of 9alpha-bromo-11beta-keto-progesterone and prednisolone in the treatment of advanced carcinoma of the female breast.
    COLSKY J
    Cancer; 1963 Apr; 16():502-5. PubMed ID: 14022451
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on the use of 5-fluorouracil in metastatic carcinoma of the breast.
    KHO MC; PARSONNET V
    J Newark Beth Isr Hosp; 1961 Apr; 12():93-100. PubMed ID: 13755702
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormonal therapy in cancer of the breast. XIII. The effect of 9 alpha-fluoro-17 alpha-methyl-delta 4-androsten3-one-11 beta-17 beta-diol (fluoxymetherone) therapy on clinical course and hormonal excretion.
    SEGALOFF A; BOWERS CY; RONGONE EL; MURISON PJ; SCHLOSSER JV
    Cancer; 1958; 11(6):1187-9. PubMed ID: 13608419
    [No Abstract]   [Full Text] [Related]  

  • 14. The hormonal therapy of advanced carcinoma of the breast.
    LEIS HP
    J Int Coll Surg; 1961 Aug; 36():225-34. PubMed ID: 13760583
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intracystic papillary carcinoma of the breast: report of three cases].
    El mazghi A; Bouhafa T; Loukili K; El kacemi H; Lalya I; Kebdani T; Hassouni K
    Pan Afr Med J; 2014; 18():207. PubMed ID: 25419333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology and behavior of small breast carcinomas.
    Meyer JS; Fahrner M; Daniel FC
    Semin Diagn Pathol; 1999 Aug; 16(3):257-68. PubMed ID: 10490202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Ketoprogesterone and its biological actions.
    NAKAO T; MATSUBA M; HIRAGA K; INABA M; HIRAI M; KANEMOTO S; YANAGITA T; SATO S; TAKEYAMA S; HISHIKAWA Y; IWASAKI M; KITAZUME M; MORI S
    Endocrinol Jpn; 1958 Sep; 5(3):149-62. PubMed ID: 13586178
    [No Abstract]   [Full Text] [Related]  

  • 18. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical comparison between GCDFP-15 and estrogen and progesterone receptors in the diagnosis of metastatic carcinoma of the breast].
    Villarroel Salinas J; Ortiz Hidalgo C; Soria Céspedes D
    Gac Med Mex; 2012; 148(3):213-7. PubMed ID: 22820353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal treatment of 200 patients with metastasized mammary carcinoma.
    BOSBOOM B; MEISCHKE-DE JONGH ML; den HERDER BA; GERBRANDY J
    Acta Physiol Pharmacol Neerl; 1959; 8():554-6. PubMed ID: 13803019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.